|
MFAP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.499800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.458000E-02 |
| Normal-vs-Stage2 |
5.802000E-01 |
| Normal-vs-Stage3 |
7.238000E-01 |
| Normal-vs-Stage4 |
4.486800E-01 |
| Stage1-vs-Stage2 |
6.420800E-01 |
| Stage1-vs-Stage3 |
1.823200E-01 |
| Stage1-vs-Stage4 |
2.911200E-01 |
| Stage2-vs-Stage3 |
5.298800E-01 |
| Stage2-vs-Stage4 |
3.774400E-01 |
| Stage3-vs-Stage4 |
5.344200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.995420E-01 |
| Normal-vs-AfricanAmerican |
6.015800E-01 |
| Normal-vs-Asian |
9.772000E-01 |
| Caucasian-vs-AfricanAmerican |
7.312800E-01 |
| Caucasian-vs-Asian |
7.973800E-01 |
| AfricanAmerican-vs-Asian |
8.807000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.986100E-02 |
| Normal-vs-Female |
1.973790E-01 |
| Male-vs-Female |
5.196700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.809800E-01 |
| Normal-vs-Extreme_Weight |
2.647700E-02 |
| Normal-vs-Obese |
6.952000E-01 |
| Normal-vs-Extreme_Obese |
3.505600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.501800E-01 |
| Normal_Weight-vs-Obese |
6.929800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.001200E-01 |
| Extreme_Weight-vs-Obese |
1.690630E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.314400E-01 |
| Obese-vs-Extreme_Obese |
5.328000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.753600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.584600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.117300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.961950E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.935400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.184500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.582090E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.636800E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.935100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.707800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.073000E-01 |
| Normal-VS-Type2 PRCC |
1.869150E-01 |
| Normal-VS-KIRP CIMP |
4.616400E-01 |
| Normal-VS-Unclassified PRCC |
4.700400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.445800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.438400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.497410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.309400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.430030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.103600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.813600E-02 |
| Normal-vs-N1 |
1.838160E-01 |
| Normal-vs-N2 |
8.577600E-01 |
| N0-vs-N1 |
4.574300E-02 |
| N0-vs-N2 |
3.957600E-01 |
| N1-vs-N2 |
6.976200E-01 |
|
|
